Cargando…
Acute interstitial nephritis with Prothionamide
Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a dru...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109270/ https://www.ncbi.nlm.nih.gov/pubmed/35585853 http://dx.doi.org/10.1177/2050313X221094076 |
_version_ | 1784708866526674944 |
---|---|
author | Asnake, Molla Henock, Andualem Abayneh, Menigistu Getu, Shimelis Hailemariam, Shewangizaw Endalkachew, Biruk Zerihun, Dessalegn |
author_facet | Asnake, Molla Henock, Andualem Abayneh, Menigistu Getu, Shimelis Hailemariam, Shewangizaw Endalkachew, Biruk Zerihun, Dessalegn |
author_sort | Asnake, Molla |
collection | PubMed |
description | Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide. |
format | Online Article Text |
id | pubmed-9109270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-91092702022-05-17 Acute interstitial nephritis with Prothionamide Asnake, Molla Henock, Andualem Abayneh, Menigistu Getu, Shimelis Hailemariam, Shewangizaw Endalkachew, Biruk Zerihun, Dessalegn SAGE Open Med Case Rep Case Report Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide. SAGE Publications 2022-05-13 /pmc/articles/PMC9109270/ /pubmed/35585853 http://dx.doi.org/10.1177/2050313X221094076 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Asnake, Molla Henock, Andualem Abayneh, Menigistu Getu, Shimelis Hailemariam, Shewangizaw Endalkachew, Biruk Zerihun, Dessalegn Acute interstitial nephritis with Prothionamide |
title | Acute interstitial nephritis with Prothionamide |
title_full | Acute interstitial nephritis with Prothionamide |
title_fullStr | Acute interstitial nephritis with Prothionamide |
title_full_unstemmed | Acute interstitial nephritis with Prothionamide |
title_short | Acute interstitial nephritis with Prothionamide |
title_sort | acute interstitial nephritis with prothionamide |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109270/ https://www.ncbi.nlm.nih.gov/pubmed/35585853 http://dx.doi.org/10.1177/2050313X221094076 |
work_keys_str_mv | AT asnakemolla acuteinterstitialnephritiswithprothionamide AT henockandualem acuteinterstitialnephritiswithprothionamide AT abaynehmenigistu acuteinterstitialnephritiswithprothionamide AT getushimelis acuteinterstitialnephritiswithprothionamide AT hailemariamshewangizaw acuteinterstitialnephritiswithprothionamide AT endalkachewbiruk acuteinterstitialnephritiswithprothionamide AT zerihundessalegn acuteinterstitialnephritiswithprothionamide |